| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |